简体
简体中文
繁體中文

Kamada KMDA 深 沪

等待开盘 10-09 09:30:00 美东时间

7.775

-0.115

-1.46%

华盛通华盛通
立即下载
  • 最 高7.8516
  • 今 开7.85
  • 成交量 6.78万股
  • 最 低 7.682
  • 昨 收 7.89
  • 总市值 4.49亿
  • 52周最高 8.96
  • 市盈率 静 22.46
  • 换手率 0.12%
  • 52周最低 6.13
  • 委 比 2.51%
  • 总股本 5771.03万
  • 历史最高 17.33
  • 量 比 0.67
  • 振 幅 2.15%
  • 历史最低 2.40
  • 每 手 1
  • 风险率 0.76%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Kamada Expands Biosimilar Portfolio With Commercial Launch Of Two Additional New Products In Israel, Adding To Existing Portfolio Of Two Products

    Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced the expansion of its biosimilar portfolio with the commercial launch of t...

    10-06 19:06

  • Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

    Kamada Ltd., a global biopharmaceutical company, has expanded its biosimilar portfolio with the launch of two new products in Israel: Ustekinumab-Kamada and Enoxaparin-Kamada. These additions bring the total biosimilar products to four, with plans for at least two more by 2027. The company expects its biosimilar portfolio to generate $4 million in sales in 2026, growing to $10 million by 2028 and $20-$25 million annually by 2030. The portfolio is...

    10-06 11:00

  • Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference

    Kamada Ltd., a global biopharmaceutical company specializing in rare and serious conditions, announced that CEO Amir London will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The presentation will be live streamed, with a replay available for 30 days. Investors can arrange one-on-one meetings with Mr. London through their H.C. Wainwright representative. Kamada focuses on organic growth, partnership...

    09-10 11:00

  • Kamada Secures Israeli Tax Ruling on Withholding for September Dividend

    Kamada ( ($IL:KMDA) ) just unveiled an update. On September 3, 2026, Kamada Ltd...

    09-04 07:30

  • Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders

    Kamada Ltd. announced it has obtained a tax ruling from the Israel Tax Authority regarding a cash dividend of $0.17 per share, totaling approximately $9.8 million, to be paid on September 17, 2026. Shareholders trading on Nasdaq who are residents of countries with an Israeli tax treaty may qualify for a reduced withholding tax rate, while Israeli corporate shareholders may be exempt from withholding tax. Documentation must be submitted to the Tax...

    09-03 20:01

  • Kamada declares $0.17 dividend

    Kamada (KMDA) declares $0.17/share dividend. Payable Sept. 17; for shareholders of record Aug. 27; ex-div Aug. 27. See KMDA Dividend Scorecard, Yield Chart, & Dividend Growth. More on Kamada Kamada Lt...

    08-17 20:29

  • Kamada CFO Chaime Orlev to step down

    Kamada (KMDA) said CFO Chaime Orlev will step down from his role effective December 31, 2026, to pursue other opportunities. The company has begun searching for his successor. Orlev, who has served as...

    08-12 19:27

  • Kamada Affirms FY2026 Sales Guidance of $200.000M-$205.000M vs $202.048M Est

    Kamada (NASDAQ:KMDA) affirms FY2026 sales outlook from $200.000 million-$205.000 million to $200.000 million-$205.000 million vs $202.048 million estimate.

    08-12 19:07

  • Kamada Q2 EPS $0.16 Beats $0.12 Estimate, Sales $54.921M Beat $50.657M Estimate

    Kamada (NASDAQ:KMDA) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.12 by 33.33 percent. This is a 23.08 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $54.921 million which bea...

    08-12 19:07

  • Kamada Announces Planned Transition of Chief Financial Officer

    Kamada Ltd. announced that Chief Financial Officer Chaime Orlev will transition out of his role effective December 31, 2026, to pursue other opportunities. Kamada is currently searching for a successor, and Orlev will provide transitional support to the new CFO. CEO Amir London thanked Orlev for his nine years of leadership and contributions to the company's growth. Orlev expressed gratitude for his tenure and confidence in Kamada's continued gro...

    08-12 11:00